BASINGSTOKE, England, Nov 15 (Bernama-BUSINESS WIRE) — A new study from Juniper Research found that the total spend on precision medicine will reach $132.3 billion globally by 2027; increasing from only $35.7 billion in 2022. This strong growth of 270% is a result of emerging technologies and infrastructure, such as AI, which aids precision medicine by predicting risks for certain diseases. These technological advancements, combined with the healthcare sector’s need to increase efficiencies in the face of an economic downturn, will encourage healthcare providers to invest further into precision medicine.
Precision medicine leverages advances in personal genomics to enable healthcare providers to prepare preventative plans and disease treatments based on gene variability.
